Literature DB >> 8088045

Characteristic bright signal of parotid pleomorphic adenomas on T2-weighted MR images with pathological correlation.

Y Tsushima1, M Matsumoto, K Endo, T Aihara, T Nakajima.   

Abstract

The purpose of this study was to correlate the MR features and histological findings of pleomorphic adenomas, which are the most common tumour of the parotid gland, and to distinguish them from other types of tumour in the parotid gland. The materials studied consisted of 20 pleomorphic adenomas, including 12 untreated and eight recurrent cases, 17 other benign parotid tumours, and 12 malignant tumours. T1- and T2-weighted images and Gd-DTPA enhanced T1-weighted images were obtained. Characteristic bright signals with a higher intensity than that of CSF were seen in all of the pleomorphic adenomas on T2-weighted images, and were found to represent myxoid areas histologically. Although the cystic spaces in some benign tumours produced bright signals, these areas were distinguished from myxoid areas due to nonenhancement with Gd-DTPA. No bright signals were seen in the malignant tumours. In conclusion, bright signals on T2-weighted images represent myxoid tissue and are useful findings for diagnosing pleomorphic adenomas.

Entities:  

Mesh:

Year:  1994        PMID: 8088045     DOI: 10.1016/s0009-9260(05)81748-9

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  15 in total

1.  Recurrent pleomorphic adenoma.

Authors:  Rachel L Werner; James T Castle
Journal:  Head Neck Pathol       Date:  2013-11-07

Review 2.  Sonographic diagnosis in the head and neck region: from an educational lecture presented at the 56th General Assembly and Annual Scientific Congress of the Japanese Society for Oral and Maxillofacial Radiology.

Authors:  Mayumi Shimizu; Warangkana Weerawanich
Journal:  Oral Radiol       Date:  2018-11-03       Impact factor: 1.852

Review 3.  Pleomorphic adenoma of salivary glands: common and uncommon CT and MR imaging features.

Authors:  Hiroki Kato; Masaya Kawaguchi; Tomohiro Ando; Keisuke Mizuta; Mitsuhiro Aoki; Masayuki Matsuo
Journal:  Jpn J Radiol       Date:  2018-05-29       Impact factor: 2.374

4.  MR imaging of parotid tumors: typical lesion characteristics in MR imaging improve discrimination between benign and malignant disease.

Authors:  A Christe; C Waldherr; R Hallett; P Zbaeren; H Thoeny
Journal:  AJNR Am J Neuroradiol       Date:  2011-06-30       Impact factor: 3.825

5.  MR imaging of salivary duct carcinoma.

Authors:  Ken Motoori; Yumiko Iida; Yuichirou Nagai; Seiji Yamamoto; Takuya Ueda; Hiroyuki Funatsu; Hisao Ito; Okamoto Yoshitaka
Journal:  AJNR Am J Neuroradiol       Date:  2005-05       Impact factor: 3.825

Review 6.  Intraparotid facial nerve schwannoma: two case reports and a review of the literature.

Authors:  M Simone; E Vesperini; C Viti; A Camaioni; L Lepanto; F Raso
Journal:  Acta Otorhinolaryngol Ital       Date:  2018-02       Impact factor: 2.124

7.  Warthin tumor of the parotid gland: diagnostic value of MR imaging with histopathologic correlation.

Authors:  Mitsuaki Ikeda; Ken Motoori; Toyoyuki Hanazawa; Yuichiro Nagai; Seiji Yamamoto; Takuya Ueda; Hiroyuki Funatsu; Hisao Ito
Journal:  AJNR Am J Neuroradiol       Date:  2004-08       Impact factor: 3.825

8.  Clinico-radiological features of primary lacrimal gland pleomorphic adenoma: an analysis of 37 cases.

Authors:  Akihide Watanabe; Nicholas H Andrew; Kosuke Ueda; Shigeru Kinoshita; Nobutada Katori; Michael Reid; Adnan Pirbhai; Dinesh Selva
Journal:  Jpn J Ophthalmol       Date:  2016-05-16       Impact factor: 2.447

Review 9.  Parotid tumors: MR imaging with pathological correlation.

Authors:  Mika Okahara; Hiro Kiyosue; Yuko Hori; Akira Matsumoto; Hiromu Mori; Shigeo Yokoyama
Journal:  Eur Radiol       Date:  2003-12       Impact factor: 5.315

10.  Basal cell adenoma of the parotid gland: MR imaging findings with pathologic correlation.

Authors:  M Okahara; H Kiyosue; S Matsumoto; Y Hori; S Tanoue; D Uchida; H Mori; Y Kondo
Journal:  AJNR Am J Neuroradiol       Date:  2006-03       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.